Lara Meisner - Sep 12, 2024 Form 3 Insider Report for Bicara Therapeutics Inc. (BCAX)

Role: Chief Legal Officer
Signature: /s/ Lara Meisner
Stock symbol: BCAX
Transactions as of: Sep 12, 2024
Transactions value $: $0
Form type: 3
Date filed: 9/12/2024, 09:20 PM
Previous filing: Jun 20, 2023
Next filing: Mar 18, 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	BCAX	Stock Option (Right to Buy)							Sep 12, 2024	Common Stock	156K	$5.45	Direct	F1
holding	BCAX	Stock Option (Right to Buy)							Sep 12, 2024	Common Stock	97.4K	$5.45	Direct	F2
holding	BCAX	Stock Option (Right to Buy)							Sep 12, 2024	Common Stock	135K	$9.24	Direct	F3

Showing 1 to 3 of 3 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares underlying this option vest on November 27, 2024, with the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
F2	The shares underlying this option vest in sixteen equal quarterly installments following December 14, 2023, subject to the Reporting Person's continued service on each such vesting date.
F3	The shares underlying this option vest in sixteen equal quarterly installments following August 6, 2024, subject to the Reporting Person's continued service on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney